ANNA ZAKHAROVA: Open Payments
NPI 1891344172 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 25 payments from 12 companies in 2025. Trend: 2023 $159 · 2024 $1,054 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $201 |
| Kestra Medical Technology Services, Inc. | 2 | $159 |
| Boston Scientific Corporation | 4 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $116 |
| BridgeBio Pharma, Inc. | 1 | $109 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| PFIZER INC. | 2 | $40 |
| Amgen Inc. | 2 | $38 |
| ABIOMED | 1 | $33 |
Products named: Ozempic, Assure WCD, WATCHMAN FLX, JARDIANCE, Kerendia, Attruby, FARXIGA, VYNDAQEL.
Industry payments across WA — which companies pay providers there.
